U.S. pharma huge copyright scrapped two experimental weight loss pills past calendar year—a at the time-every day pill, lotiglipron, resulting from elevated liver enzymes and a twice-daily pill, danuglipron, on account of solid Unwanted side effects—but CEO Albert Bourla has mentioned the company is set to “Engage in and acquire” within the